CAS will make a decision on Valieva’s case in January 2024 – Kommersant
[ad_1]
The Court of Arbitration for Sport (CAS) has completed hearings in the case of Russian figure skater Kamila Valieva, whose sample was found to contain the banned drug trimetazidine. CAS plans to make a final decision in January 2024, said press service court.
The fact that trimetazidine was detected in Kamila Valieva’s sample taken in December 2021 at the Russian Championships in St. Petersburg, became known a month and a half later, during the Olympics in Beijing, shortly after the end of the team tournament, which the Russian team won. At the same time, Valieva brought the team 20 out of 74 points.
The Russian Anti-Doping Agency (RUSADA), following an investigation into the incident with the figure skater, stated that Valieva had committed a doping violation, but did not find any signs of “guilt or negligence” in her actions and considered it unacceptable to apply any sanctions against the skater other than the annulment of the results, shown on the day she tested positive.
The World Anti-Doping Agency (WADA) and the International Skating Union (ISU) did not agree with this interpretation of the incident. They appealed to CAS. WADA is seeking a four-year disqualification for Valieva (the period starts from December 25, 2021) with the cancellation of all results shown after the positive test. The ISU agrees to a two-year suspension.
The athlete herself does not admit guilt. The girl’s defense claims that trimetazidine is used by Valieva’s grandfather after heart surgery, who took her to training and home. The athlete assumes that the use of the drug occurred through the dishes that she and her grandfather used, including through liquid drunk from the same glass.
Read more about the CAS hearings in the material “Kamila Valieva will fight for innocence”.
[ad_2]
Source link
